Immunotherapy Drugs Global Market 2023: Sector to Reach $327.8 Billion by 2028 at a CAGR of 9.01%


Dublin, Feb. 10, 2023 (GLOBE NEWSWIRE) -- The "Immunotherapy Drugs Market by Type, Therapy Area, End User, and Region 2023-2028" report has been added to ResearchAndMarkets.com's offering.

The global immunotherapy drugs market size reached US$ 195.4 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 327.8 Billion by 2028, exhibiting a CAGR of 9.01% during 2022-2028.

Companies Mentioned

  • AstraZeneca plc
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche AG
  • GSK plc
  • Merck & Co. Inc.
  • Pfizer Inc.
  • Sanofi S.A.

Immunotherapy drugs are specialized medications used for treating lymphoma, melanoma, sarcoma, and lung, bladder, kidney, and breast cancer. They target specific cells of the immune system and boost energy levels. They stimulate the natural defenses of the body and help fight against allergies and infections caused by bacteria and viruses.

They also aid in preventing the growth of cancer cells by triggering an immunological response that aids in generating antibodies. Moreover, as they are effective in minimizing the complications of tumors and other chronic disorders, the demand for immunotherapy drugs is rising across the globe.

The growing global geriatric population and the rising prevalence of cancer, tumor, and target diseases worldwide represent one of the key factors positively influencing the market. In addition, hectic schedules and the increasing occurrence of various genetic and lifestyle diseases are catalyzing the demand for immunotherapy drugs across the globe.

Apart from this, the escalating demand for monoclonal antibodies and biosimilar drugs is offering lucrative growth opportunities to manufacturers.

This, in confluence with the rising awareness among individuals and healthcare professionals about the benefits of early diagnosis and treatment of cancer, is increasing the overall sales of immunotherapy drugs. Furthermore, the increasing focus of key market players on strategic collaborations and new product developments to expand their product portfolio and gain a competitive edge is propelling the market growth.

Additionally, the expansion of hospitals, pharmacies, and research laboratories across the globe is offering a favorable market outlook. Moreover, increasing investments by leading pharmaceutical and biotechnology companies in research and development (R&D) activities to enhance the formulation of immunotherapy drugs are expected to drive the market.

Key Questions Answered in This Report:

  • How has the global immunotherapy drugs market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global immunotherapy drugs market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the therapy area?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global immunotherapy drugs market and who are the key players?
  • What is the degree of competition in the industry?

Key Topics Covered:

1 Preface

2 Scope and Methodology

3 Executive Summary

4 Introduction
4.1 Overview
4.2 Key Industry Trends

5 Global Immunotherapy Drugs Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast

6 Market Breakup by Drug Type
6.1 Monoclonal Antibodies
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Vaccines
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Interferons Alpha and Beta
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Interleukins
6.4.1 Market Trends
6.4.2 Market Forecast

7 Market Breakup by Therapy Area
7.1 Cancer
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Autoimmune and Inflammatory Diseases
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Infectious Diseases
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast

8 Market Breakup by End User
8.1 Hospitals
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Clinics
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast

9 Market Breakup by Region

10 SWOT Analysis

11 Value Chain Analysis

12 Porters Five Forces Analysis

13 Price Analysis

14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players

For more information about this report visit https://www.researchandmarkets.com/r/lhmq59

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

 

Coordonnées